Exchange: NASDAQ·Updated 10:49 AM EDT

GBIM GlobeImmune

$0.0001
$0.00
(0.00%)
Today
Mkt Cap$575.00
Vol35,900.00

About GBIM

GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
49

Neutral Sentiment

How do you feel about GBIM?

Advertisement|Remove ads.